Tris Pharma, Inc.

Release Summary

Tris Pharma presented results from a laboratory classroom study of DYANAVEL® XR (amphetamine) in children with ADHD at the 2017 APSARD Annual Meeting held in Washington, D.C.

Tris Pharma, Inc.